All In Biotech

Drug Trial Radar · NCT03243006

Effect of Early Pain Management at Triage on Opioid Consumption

Effect of Early Analgesic Treatment on Opioid Consumption

Last checked: Nov 19, 2026Latest source record: Nov 30, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 1,500 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,500

Actual

Start

Jan 1, 2016

Primary completion

Sep 30, 2016

Study completion Sep 30, 2016

Sponsor

Lead sponsor
University of MonastirAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Aug 8, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Supportive care
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

introduction: Pain remains one of the most common reasons of emergency department admission. Opioids are overprescribed in emergency departments to treat severe pain. objective: assessing the impact of ealy pain pain management on the use of intravenous morphine and on patient satisfaction.

Conditions

  • Acute Pain

Interventions

  • ParacetamolDrug

    2 tablets of 500mg of paracetamol

  • Tramadol/Paracetamol combinationDrug

    2 tablets of tramadol/paracetamol combination (32.5mg/325mg)

  • Placebo Oral TabletDrug

    2 tablets of placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. use of rescue opioidsTime frame: DURING emergency department stay

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.